Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. [electronic resource]
Producer: 20091208Description: 261-8 p. digitalISSN:- 1873-4596
- Acetylcysteine -- pharmacology
- Active Transport, Cell Nucleus -- drug effects
- Buthionine Sulfoximine -- pharmacology
- Cell Nucleus -- metabolism
- Enzyme Inhibitors -- pharmacology
- Gene Expression Regulation, Viral
- Glutathione -- metabolism
- HIV Infections -- genetics
- HIV-1 -- physiology
- HeLa Cells
- Humans
- Intracellular Signaling Peptides and Proteins -- genetics
- Kelch-Like ECH-Associated Protein 1
- NF-E2-Related Factor 2 -- genetics
- RNA, Small Interfering -- genetics
- Reactive Oxygen Species
- Terminal Repeat Sequences -- genetics
- Transcriptional Activation -- drug effects
- Virus Replication -- drug effects
- tat Gene Products, Human Immunodeficiency Virus -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.